Clostridium difficile colitis in patients undergoing lower-extremity arthroplasty: Rare infection with major impact

Clinical Orthopaedics and Related Research

Volumn 471, Issue 10, 2013, Pages 3178-3185

  Maltenfort, Mitchell Gil ^a   Rasouli, Mohammad R ^a   Morrison, Todd A ^a   Parvizi, Javad ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTHROPLASTY; CLOSTRIDIUM DIFFICILE INFECTION; COMORBIDITY; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HIP ARTHROPLASTY; HOSPITAL CHARGE; HUMAN; ICD-9-CM; INCIDENCE; INFECTION RATE; INFECTION RISK; KNEE ARTHROPLASTY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RARE DISEASE; RISK ASSESSMENT; RISK FACTOR; SURGICAL INFECTION; TOTAL JOINT ARTHROPLASTY;

EID: 84884704113     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-013-2906-x     Document Type: Conference Paper

References (34)

1. Agency for Healthcare Research and Quality. Healthcare Cost & Utilization Project: database and related tools from HCUP. Available at: http://www.hcup-us.ahrq.gov/toolssoftware/comorbidity/Table2-FY12-V3-7.pdf. Accessed February 18, 2013.
2. Al-Obaydi W, Smith CD, Foguet P. Changing prophylactic antibiotic protocol for reducing Clostridium difficile-associated diarrhoeal infections. J Orthop Surg (Hong Kong). 2010;18:320-323.
3. Badger VO, Ledeboer NA, Graham MB, Edmiston CE Jr. Clostridium difficile: epidemiology, pathogenesis, management, and prevention of a recalcitrant healthcare-associated pathogen. JPEN J Parenter Enteral Nutr. 2012;36:645-662.
4. Bobo LD, Dubberke ER, Kollef M. Clostridium difficile in the ICU: the struggle continues. Chest. 2011;140:1643-1653.
5. Bottle A, Aylin P. Comorbidity scores for administrative data benefited from adaptation to local coding and diagnostic practices. J Clin Epidemiol. 2011;64:1426-1433.
6. Bureau of Labor Statistics. CPI inflation calculator. Available at: http://data.bls.gov/cgi-bin/cpicalc.pl. Accessed February 27, 2013.
7. Carignan A, Allard C, Pépin J, Cossette B, Nault V, Valiquette L. Risk of Clostridium difficile infection after perioperative antibacterial prophylaxis before and during an outbreak of infection due to a hypervirulent strain. Clin Infect Dis. 2008;46:1838-1843.
8. Carr AJ, Robertsson O, Graves S, Price AJ, Arden NK, Judge A, Beard DJ. Knee replacement. Lancet. 2012;379:1331-1340.
9. Chu YT, Ng YY, Wu SC. Comparison of different comorbidity measures for use with administrative data in predicting short- and long-term mortality. BMC Health Serv Res. 2010;10:140.
10. Clarke HJ, Jinnah RH, Byank RP, Cox QG. Clostridium difficile infection in orthopaedic patients. J Bone Joint Surg Am. 1990;72:1056-1059.
11. Csikesz NG, Nguyen LN, Tseng JF, Shah SA. Nationwide volume and mortality after elective surgery in cirrhotic patients. J Am Coll Surg. 2009;208:96-103.
12. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36:8-27.
13. Forster AJ, Taljaard M, Oake N, Wilson K, Roth V, van Walraven C. The effect of hospital-acquired infection with Clostridium difficile on length of stay in hospital. CMAJ. 2012;184:37-42.
14. Jawa RS, Mercer DW. Clostridium difficile-associated infection: a disease of varying severity. Am J Surg. 2012;204:836-842.
15. Jenkins PJ, Teoh K, Simpson PM, Dave J, Simpson AH, Breusch S. Clostridium difficile in patients undergoing primary hip and knee replacement. J Bone Joint Surg Br. 2010;92:994-998.
16. Jobe BA, Grasley A, Deveney KE, Deveney CW, Sheppard BC. Clostridium difficile colitis: an increasing hospital-acquired illness. Am J Surg. 1995;169:480-483.
17. Kaplan GG, Hubbard J, Panaccione R, Shaheen AA, Quan H, Nguyen GC, Dixon E, Ghosh S, Myers RP. Risk of comorbidities on postoperative outcomes in patients with inflammatory bowel disease. Arch Surg. 2011;146:959-964.
18. Kirksey M, Chiu YL, Ma Y, Della Valle AG, Poultsides L, Gerner P, Memtsoudis SG. Trends in in-hospital major morbidity and mortality after total joint arthroplasty: United States 1998-2008. Anesth Analg. 2012;115:321-327.
19. Kurd MF, Pulido L, Joshi A, Purtill JJ, Parvizi J. Clostridium difficile infection after total joint arthroplasty: who is at risk? J Arthroplasty. 2008;23:839-842.
20. Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89:780-785.
21. Kyne L, Warny M, Qamar A, Kelly CP. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med. 2000;342:390-397.
22. Lix LM, Quail J, Teare G, Acan B. Performance of comorbidity measures for predicting outcomes in population-based osteoporosis cohorts. Osteoporos Int. 2011;22:2633-2643.
23. McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med. 1989;320:204-210.
24. Morris AM, Jobe BA, Stoney M, Sheppard BC, Deveney CW, Deveney KE. Clostridium difficile colitis: an increasingly aggressive iatrogenic disease? Arch Surg. 2002;137:1096-1100.
25. Pivec R, Johnson AJ, Mears SC, Mont MA. Hip arthroplasty. Lancet. 2012;380:1768-1777.
26. Ricciardi R, Rothenberger DA, Madoff RD, Baxter NN. Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. Arch Surg. 2007;142:624-631.
27. Sharabiani MT, Aylin P, Bottle A. Systematic review of comorbidity indices for administrative data. Med Care. 2012;50:1109-1118.
28. Sharma P, Bomireddy R, Phillips S. Clostridium difficile-associated diarrhoea after internal fixation of intertrochanteric femoral fractures. Eur J Clin Microbiol Infect Dis. 2003;22:615-618.
29. Shen Y, Silverstein JC, Roth S. In-hospital complications and mortality after elective spinal fusion surgery in the United States: a study of the nationwide inpatient sample from 2001 to 2005. J Neurosurg Anesthesiol. 2009;21:21-30.
30. Slobogean GP, Kennedy SA, Davidson D, O'Brien PJ. Single- versus multiple-dose antibiotic prophylaxis in the surgical treatment of closed fractures: a meta-analysis. J Orthop Trauma. 2008;22:264-269.
31. Stewart DB, Hollenbeak CS. Clostridium difficile colitis: factors associated with outcome and assessment of mortality at a national level. J Gastrointest Surg. 2011;15:1548-1555.
32. Wang L, Stewart DB. Increasing hospital costs for Clostridium difficile colitis: type of hospital matters. Surgery. 2011;150:727-735.
33. Yam FK, Smith KM. "Collateral damage": antibiotics and the risk of Clostridium difficile infection. Orthopedics. 2005;28:275-279.
34. Zerey M, Paton BL, Lincourt AE, Gersin KS, Kercher KW, Heniford BT. The burden of Clostridium difficile in surgical patients in the United States. Surg Infect. 2007;8:557-566.